Abstract
Telomeres form the ends of human chromosomes. Telomeres shorten with each round of cell division and this mechanism limits proliferation of human cells to a finite number of cell divisions by inducing replicative senescence, differentiation, or apoptosis. Telomere shortening can act as a tumor suppressor. However, as a downside, there is growing evidence indicating that telomere shortening also limits stem cell function, regeneration, and organ maintenance during ageing. Moreover, telomere shortening during ageing and disease is associated with increasing cancer risk. In this review we summarize our current knowledge on the role of telomere shortening in human ageing, chronic diseases, and cancer.
Zusammenfassung
Telomere bilden die Endstücke menschlicher Chromosomen und sind für den Erhalt der Chromosomenstabilität essentiell. Telomere verkürzen sich aber mit jeder Zellteilung, wodurch die proliferative Lebesspanne menschlicher Zellen limitiert wird, da bei einer kritischen Verkürzung der Telomere Seneszenz, Stammzelldifferenzierung oder Apoptose induziert wird. Diese Telomer-abhängige Begrenzung der Lebensspanne menschlicher Zellen wird allgemein als Tumorsuppressormechanismus angesehen. Es gibt aber zunehmend Hinweise, dass die Verkürzung der Telomere auch nachteilige Auswirkungen im Rahmen der Alterung haben kann, da hierdurch die Funktion von Stammzellen und die regenerative Reserve der Organe beschränkt wird. Darüber hinaus ist die Verkürzung der Telomere im Rahmen der menschlichen Alterung und bei chronischen Erkrankungen mit einem erhöhten Tumorrisiko assoziiert. In dieser Übersicht fassen wir unser aktuelles Wissen über die Rolle von Telomeren in der Alterung, bei chronischen Erkrankungen und hinsichtlich der Krebsentstehung zusammen.
Similar content being viewed by others
References
Blackburn EH (2001) Switching and signaling at the telomere. Cell 106:661–673
de Lange T (2004) T-loops and the origin of telomeres. Nat Rev Mol Cell Biol 5(4):323–329
Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89(21):10114–10118
Lingner J, Cooper JP, Cech TR (1995) Telomerase and DNA end replication: no longer a lagging strand problem? Science 269(5230):1533–1534
Saretzki G, Von Zglinicki T (2002) Replicative aging, telomeres, and oxidative stress. Ann NY Acad Sci 959:24–29
Greider CW (1996) Telomere length regulation. Annu Rev Biochem 65:337–365
d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (6963):194–198
Wright WE, Shay JW (1992) The twostage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27:383–389
Djojosubroto MW, Choi YS, Lee HW, Rudolph KL (2003) Telomeres and telomerase in aging, regeneration and cancer. Mol Cells 15:164–175
Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB (1995) Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220(1):194–200
Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB (2003) Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24(1):77–84
Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T (2006) Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 60(2):174–180
Boukamp P (2005) Skin aging: a role for telomerase and telomere dynamics? Curr Mol Med 5(2):171–177
Nakamura K, Izumiyama-Shimomura N, Sawabe M, Arai T, Aoyagi Y, Fujiwara M, Tsuchiya E, Kobayashi Y, Kato M, Oshimura M, Sasajima K, Nakachi K, Takubo K (2002) Aomparative analysis of telomere lengths and erosion with age in human epidermis and lingual epithelium. J Invest Dermatol 119(5):1014–1019
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92(20):9363–9367
de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, Varmus HE (1990) Structure andvariability of human chromosome ends. Mol Cell Biol 10(2):518–527
Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91(21):9857–9860
Zimmermann S, Martens UM (2005) Telomere dynamics in hematopoietic stem cells. Curr Mol Med 5(2):179–185
Gutierrez L, Ju Z (2007) Telomere shortening induces cell intrinsic checkpoints and environmental alterations limiting adult stem cell function. In: Rudolph KL. Telomeres and Telomerase in Aging, Disease, and Cancer. Springer Publishing 2007 (In press)
Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, Klempnauer J, Flemming P, Franco S, Blasco MA, Manns MP, Rudolph KL (2002) Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16(9):935–942
Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang C, Buer J, Lee HW, von Zglinicki T, Ganser A, Schirmacher P, Nakauchi H, Rudolph KL (2007) Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 39(1):99–105
Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125(7):1253–1267
Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361(9355):393–395
Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ; West of Scotland Coronary Prevention Study Group (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369(9556):107–114
van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ; MERIT-HF Study Group (2007) Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 49(13):1459–1464
Martin-Ruiz CM, Gussekloo J, van Heemst D, von Zglinicki T, Westendorp RG (2005) Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell 4(6):287–290
Ganser A, Hoelzer D (1992) Clinical course of myelodysplastic syndromes. Hematol Oncol Clin North Am 6(3):607–618
Ju Z, Rudolph KL (2006) Telomeres and telomerase in cancer stem cells. Eur J Cancer 42(9):1197–1203
Blasco, MA, Lee HW, Hande MP, Samper E, Lansdorp PM, dePinho RA, Greider CW (1997) Telomere shortening and tumour formation by mouse cells lacking telomerase RNA. Cell 91:25–34
Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA (1999) Longevity, stress response, and cancer in ageing telomerase-deficient mice. Cell 96:701–712
Satyanarayana A, Wiemann SU, Buer J, Lauber J, Dittmar KE, Wustefeld T, Blasco MA, Manns MP, Rudolph KL (2003) Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J 22(15):4003–4013
Ju Z, Jiang H, Jaworski M, Rathinam C, Gompf A, Klein C, Trumpp A, Rudolph KL (2007) Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med 13(6):742–747
Brown JP, Wei W, Sedivy JM (1997) Bypasss of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277(5327):831–834
Mason PJ, Wilson DB, Bessler M (2005) Dyskeratosis congenita – a disease of dysfunctional telomere maintenance. Curr Mol Med 5(2):159–170
Mitchell JR, Wood E, Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402(6761):551–555
Young NS (2006) Pathophysiologic mechanisms in acquired aplastic anemia. Hematology Am Soc Hematol Educ Program, pp 72–77
Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA 3rd, Lansdorp PM, Greider CW, Loyd JE (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356(13):1317–1326
Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK (2007) Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 104(18):7552–7557
Smogorzewska A, Karlseder J, Holtgreve- Grez H, Jauch A, de Lange T (2002) DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol 12(19):1635–1644
Maser RS, Wong KK, Sahin E, Xia H, Naylor M, Hedberg HM, Artandi SE, DePinho RA (2007) DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol Cell Biol 27(6):2253–2265
Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406(6796):641–645
Lechel A, Holstege H, Begus Y, Schienke A, Kamino K, Lehmann U, Kubicka S, Schirmacher P, Janker J, Rudolph KL (2007) Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease. Gastroenterology 132(4):1465–1475
Author information
Authors and Affiliations
Corresponding author
Additional information
Hong Jiang Formerly: Institute and Max-Planck-Research Group of Molecular Medicine Ulm University Ulm, Germany
Rights and permissions
About this article
Cite this article
Jiang, H., Ju, Z. & Rudolph, K.L. Telomere shortening and ageing. Z Gerontol Geriat 40, 314–324 (2007). https://doi.org/10.1007/s00391-007-0480-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00391-007-0480-0